Stuart Kauffman, DO
Family Medicine · Clearwater, FLNPI 1124137088
Payments from drug & device makers
Across 120 payments — averaging $31.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$599
- Liberty Surgical Inc.$195
- Eisai Inc.$114
- Scilex Pharmaceuticals Inc.$113
- Lilly USA, LLC$105
- plus $748 from 20 others
What the payments were for
- Travel & lodging$1674%
- Food & beverage$1,74246%
- Education$1,87250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 5 | $1,907 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 53 | $599 |
| Liberty Surgical Inc. | 2 | $195 |
| Eisai Inc. | 1 | $114 |
| Scilex Pharmaceuticals Inc. | 6 | $113 |
| Lilly USA, LLC | 6 | $105 |
| Biodelivery Sciences International, Inc. | 6 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $84 |
| Pfizer | 6 | $82 |
| Orexo US, Inc. | 3 | $64 |
| Novo Nordisk | 3 | $61 |
| West Therapeutics Development, LLC | 3 | $40 |
| Amarin Pharma, Inc. | 2 | $40 |
| Avanir Pharmaceuticals, Inc. | 2 | $37 |
| Bausch Health US, LLC | 2 | $35 |
| AstraZeneca | 2 | $31 |
| Johnson & Johnson(2 entities) | 2 | $30 |
| Exact Sciences | 1 | $29 |
| Merck | 2 | $29 |
| Shionogi Inc | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $13 |
| AbbVie | 1 | $12 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Leqembi$114
How this compares
$3,781 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 11 | $10,759 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $865 |
| Cephalexin | 20 | $663 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 43 | $585 |
| Cefdinir | 37 | $505 |
| Clindamycin Hcl | 49 | $341 |
| Methylprednisolone | 28 | $197 |
| Azithromycin | 38 | $186 |
| Amoxicillin | 30 | $171 |
| Dexamethasone | 20 | $170 |
| Doxycycline Hyclate | 17 | $166 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $145 |
| Fluticasone Propionate | 15 | $135 |
| Prednisone | 66 | $123 |
| Ciprofloxacin Hcl | 19 | $97 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Clearwater
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.